Posted May. 22, 2012 at 12:34 p.m.
Chelsea
Research Triangle Park, N.C. — The therapeutics firm announced the plans following its meeting with the U.S. Food and Drug Administration to discuss the complete response letter received for Northera, a compound developed to treat dizziness and fainting in Parkinson's disease patients....
Charlotte-based Chelsea retargets new drug application for 2013
Post a comment
Print this blog postE-mail blog post
Share
Chelsea
Research Triangle Park, N.C. — The therapeutics firm announced the plans following its meeting with the U.S. Food and Drug Administration to discuss the complete response letter received for Northera, a compound developed to treat dizziness and fainting in Parkinson's disease patients....
WRAL Tech Wire any time: Twitter, Facebook
Copyright 2013 MedCity. All rights reserved.Please log in or register to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
Best of TechWire Insider
OUR INSIDERS
WRAL TechWire Editor
The Skinny
At last! Sprint 4G service formally launches in Triangle- Big Blue's layoff total climbs in RTP; North America total surges past 2,800
- Big Blue layoff count nears 2,800 in North America alone
- NC's high-tech job picture improves in May, but ...
- IBM layoff count hits nearly 2,300 across 31 work groups
- NC IDEA: Startup deal flow 'better than it has ever been'
- IBM's job cuts are global, nearing 4,000; most are in U.S.
- CEO fears for future of NC Biofuels Center due to budget cuts
- Workers 50+ take biggest hit among 14% reduction in IBM marketing group
- 'Anxiety and disruption:' IBM's form letter for layoffs